Controversy over Effects of Tamiflu Continues

Controversy over Effects of Tamiflu Continues

In a recent report, the department of health has made it clear that patients having fragile immune system must take Tamiflu. Though there are questions raised over the positive effects of the antiviral drug, there are reports recommending the drug for time being.

It has been told that there were glaring reports in the British Medical Journal (BMJ) about the drug reducing the life of patients, though no tangible evidence could be find out. Even a team from the Cochrane Collaboration has peeped into 20 studies concerning the same issue, and claimed that the drug could not reduce the risk related with influenza-related lower respiratory tract complications. As of now, there are no clear cut reports being released for people to follow.

Even pharmaceutical giant Roche is being lashed out for not conducting the study with complete evidence, which has been completely denied by the company. It was told that despite incessant requests to the company, no extended support was given to the current investigators. However, Roche is of the say that they have provided all the available details of the study in the peer-reviewed publications or in summary form on www. roche-trials. com.

Despite the controversy, the UK government is accepting contracts for 50 million doses of Tamiflu. "We cannot be certain whether the trial evidence supports the conclusion that (Tamiflu) reduces complications”, the report said. “Nor do we understand if and how (Tamiflu) changes immune response, and important questions about its mode of action remain”.

It is required that rational decisions are being made after taking into account all possible angles of the underlying theory. Even Dr. Fiona Godlee, Editor-In-Chief of the BMJ has asserted that it would take some more time to actually reach to the conclusion about the drug.

As of now, patients are being given the same drug to beat the risk of flu, but final report concerning the same is awaited.


FrenchTribune Specials

NHTSA pushing for introduction of V2V transmitters on US cars

The US National Highway Traffic Safety Administration (NHTSA) pushing for the introduction of vehicle-to-vehicle (V2V) transmitters and accompanying software for averting hundreds of thousands of crashes in the US every year.

As a result of the NHTSA's efforts, it is possible that the vehicles in the US may be equipped with V2V...

Most Popular

Surfing is No Less than Therapy for Cystic Fibrosis Patient

Cystic fibrosis is a genetic condition that affects...

Insurance Discrimination faced by Patients Including High Medication Costs

More than 300 patient advocacy groups recently wrote...

FDA Rejects Teen Suicide Victim’s Eyes Owing to his Gay Status

Food and Drug Administration rejected donation of a...

esearchers Find Sixth Hole During Last 6 Weeks in Mount Baldy

Researchers have been actively looking out for holes in...

Poll

Can Greece Come out of Economic Problems: